PDCD1 and ovarian carcinoma: Newly diagnosed advanced ovarian cancer.Durvalumab (Imfinzi) (anti-PD-1 mAb) in combination with platinum-based chemotherapy and Bevacizumab followed by maintenance Durvalumab and Bevacizumab or Durvalumab, Bevacizumab and Olaparib (poly ADP ribose polymerase (PARP) inhibitor).Randomised, double-blind.